Receptor tyrosine kinase c-Met controls the cytoskeleton from different endosomes via different pathways

Nature Communications

Volumn 5, Issue , 2014, Pages

  Ménard, Ludovic ^a,b   Parker, Peter J ^b,c   Kermorgant, Stéphanie ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; RAC1 PROTEIN; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG; VAV2 PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAC1 PROTEIN, HUMAN; TIAM1 PROTEIN, HUMAN; VAV PROTEIN; VAV2 PROTEIN, HUMAN;

CELL ORGANELLE; ENZYME ACTIVITY; MEMBRANE;

ACTIN FILAMENT; ARTICLE; BREAST CELL; CANCER MODEL; CELL INVASION; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MOLECULAR MODEL; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; CELL MOTION; METABOLISM;

ACTIN CYTOSKELETON; CELL MOVEMENT; ENDOSOMES; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-MET; PROTO-ONCOGENE PROTEINS C-VAV; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 84901020430     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4907     Document Type: Article

References (70)

1. Miaczynska, M., Pelkmans, L. & Zerial, M. Not just a sink: endosomes in control of signal transduction. Curr. Opin. Cell Biol. 16, 400-406 (2004). (Pubitemid 38903146)
2. Kermorgant, S. & Parker, P. J. c-Met signalling: spatio-temporal decisions. Cell Cycle 4, 352-355 (2005). (Pubitemid 41359712)
3. Gould, G. W. & Lippincott-Schwartz, J. New roles for endosomes: from vesicular carriers to multi-purpose platforms. Nat. Rev. Mol. Cell Biol. 10, 287-292 (2009).
4. Sorkin, A. & von Zastrow, M. Endocytosis and signalling: intertwining molecular networks. Nat. Rev. Mol. Cell Biol. 10, 609-622 (2009).
5. Scita, G. & Di Fiore, P. P. The endocytic matrix. Nature 463, 464-473 (2010).
6. Platta, H. W. & Stenmark, H. Endocytosis and signaling. Curr. Opin. Cell Biol. 23, 393-403 (2011).
7. Teis, D., Wunderlich, W. & Huber, L. A. Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. Dev. Cell 3, 803-814 (2002). (Pubitemid 35460781)
8. Schenck, A. et al. The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development. Cell 133, 486-497 (2008). (Pubitemid 351608689)
9. Palamidessi, A. et al. Endocytic trafficking of Rac is required for the spatial restriction of signaling in cell migration. Cell 134, 135-147 (2008). (Pubitemid 351905741)
10. Joffre, C. et al. A direct role for Met endocytosis in tumorigenesis. Nat. Cell Biol. 13, 827-837 (2011).
11. Hammond, D. E., Urbe, S., Vande Woude, G. F. & Clague, M. J. Down-regulation of MET, the receptor for hepatocyte growth factor. Oncogene 20, 2761-2770 (2001). (Pubitemid 32549833)
12. Kamei, T. et al. Coendocytosis of cadherin and c-Met coupled to disruption of cell-cell adhesion in MDCK cells-regulation by Rho, Rac and Rab small G proteins. Oncogene 18, 6776-6784 (1999).
13. Abella, J. V., Parachoniak, C. A., Sangwan, V. & Park, M. Dorsal ruffle microdomains potentiate Met receptor tyrosine kinase signaling and down-regulation. J. Biol. Chem. 285, 24956-24967 (2010).
14. Kermorgant, S., Zicha, D. & Parker, P. J. Protein kinase C controls microtubule-based traffic but not proteasomal degradation of c-Met. J. Biol. Chem. 278, 28921-28929 (2003). (Pubitemid 36935802)
15. Kermorgant, S., Zicha, D. & Parker, P. J. PKC controls HGF-dependent c-Met traffic, signalling and cell migration. EMBO J. 23, 3721-3734 (2004). (Pubitemid 39389704)
16. Kermorgant, S. & Parker, P. J. Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation. J. Cell Biol. 182, 855-863 (2008).
17. Janssens, K., Sung, H. H. & Rorth, P. Direct detection of guidance receptor activity during border cell migration. Proc. Natl Acad. Sci. USA 107, 7323-7328 (2010).
18. Mosesson, Y., Mills, G. B. & Yarden, Y. Derailed endocytosis: an emerging feature of cancer. Nat. Rev. Cancer 8, 835-850 (2008).
19. Ridley, A. J., Comoglio, P. M. & Hall, A. Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells. Mol. Cell Biol. 15, 1110-1122 (1995).
20. Ishibe, S., Joly, D., Liu, Z. X. & Cantley, L. G. Paxillin serves as an ERK-regulated scaffold for coordinating FAK and Rac activation in epithelial morphogenesis. Mol. Cell 16, 257-267 (2004). (Pubitemid 39388840)
21. Chianale, F. et al. Diacylglycerol kinase alpha mediates HGF-induced Rac activation and membrane ruffling by regulating atypical PKC and RhoGDI. Proc. Natl Acad. Sci. USA 107, 4182-4187 (2010).
22. Takahashi, K. & Suzuki, K. Requirement of kinesin-mediated membrane transport of WAVE2 along microtubules for lamellipodia formation promoted by hepatocyte growth factor. Exp. Cell Res. 314, 2313-2322 (2008).
23. DerMardirossian, C. & Bokoch, G. M. GDIs: central regulatory molecules in Rho GTPase activation. Trends. Cell Biol. 15, 356-363 (2005). (Pubitemid 40943524)
24. Myers, K. R. & Casanova, J. E. Regulation of actin cytoskeleton dynamics by Arf-family GTPases. Trends. Cell Biol. 18, 184-192 (2008).
25. Koga, F., Tsutsumi, S. & Neckers, L. M. Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells. Cell Cycle 6, 1393-1402 (2007). (Pubitemid 47327975)
26. Birchmeier, C., Birchmeier, W., Gherardi, E. & Vande Woude, G. F. Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4, 915-925 (2003). (Pubitemid 37493640)
27. Trusolino, L. & Comoglio, P. M. Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat. Rev. Cancer 2, 289-300 (2002). (Pubitemid 37328782)
28. Zhang, Y. W. & Vande Woude, G. F. HGF/SF-met signaling in the control of branching morphogenesis and invasion. J. Cell. Biochem. 88, 408-417 (2003). (Pubitemid 36119916)
29. Gentile, A., Trusolino, L. & Comoglio, P. M. The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev. 27, 85-94 (2008).
30. Welm, A. L., Kim, S., Welm, B. E. & Bishop, J. M. MET and MYC cooperate in mammary tumorigenesis. Proc. Natl Acad. Sci. USA 102, 4324-4329 (2005). (Pubitemid 40397110)
31. Lengyel, E. et al. C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu. Int. J. Cancer 113, 678-682 (2005). (Pubitemid 40038747)
32. Beviglia, L., Matsumoto, K., Lin, C. S., Ziober, B. L. & Kramer, R. H. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression. Int. J. Cancer 74, 301-309 (1997). (Pubitemid 27321800)
33. Ghoussoub, R. A. et al. Expression of c-met is a strong independent prognostic factor in breast carcinoma. Cancer 82, 1513-1520 (1998). (Pubitemid 28164998)
34. Camp, R. L., Rimm, E. B. & Rimm, D. L. Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer 86, 2259-2265 (1999). (Pubitemid 30010366)
35. Tolgay Ocal, I., Dolled-Filhart, M., D'Aquila, T. G., Camp, R. L. & Rimm, D. L. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors. Cancer 97, 1841-1848 (2003). (Pubitemid 36397257)
36. Garcia, S. et al. Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype. Hum. Pathol. 38, 830-841 (2007). (Pubitemid 46726507)
37. Ponzo, M. G. et al. Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer. Proc. Natl Acad. Sci. USA 106, 12903-12908 (2009).
38. Graveel, C. R. et al. Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer. Proc. Natl Acad. Sci. USA 106, 12909-12914 (2009).
39. Ho-Yen, C. M. et al. C-Met in invasive breast cancer: is there a relationship with the basal-like subtype? Cancer 120, 163-171 (2013).
40. Shattuck, D. L., Miller, J. K., Carraway, 3rd K. L. & Sweeney, C. Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells. Cancer Res. 68, 1471-1477 (2008). (Pubitemid 351346855)
41. Mueller, K. L., Hunter, L. A., Ethier, S. P. & Boerner, J. L. Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells. Cancer Res. 68, 3314-3322 (2008).
42. Lee, W. Y. et al. Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients. Clin. Cancer Res. 11, 2222-2228 (2005).
43. Macia, E. et al. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10, 839-850 (2006).
44. Feng, Y., Press, B. & Wandinger-Ness, A. Rab 7: an important regulator of late endocytic membrane traffic. J. Cell Biol. 131, 1435-1452 (1995). (Pubitemid 26001749)
45. Vitelli, R. et al. Role of the small GTPase Rab7 in the late endocytic pathway. J. Biol. Chem. 272, 4391-4397 (1997). (Pubitemid 27078515)
46. Parachoniak, C. A., Luo, Y., Abella, J. V., Keen, J. H. & Park, M. GGA3 functions as a switch to promote Met receptor recycling, essential for sustained ERK and cell migration. Dev. Cell 20, 751-763 (2011).
47. Nystrom, M. L. et al. Development of a quantitative method to analyse tumour cell invasion in organotypic culture. J. Pathol. 205, 468-475 (2005). (Pubitemid 40361335)
48. Stoker, M., Gherardi, E., Perryman, M. & Gray, J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327, 239-242 (1987). (Pubitemid 17071053)
49. Gampel, A. & Mellor, H. Small interfering RNAs as a tool to assign Rho GTPase exchange-factor function in vivo. Biochem. J. 366, 393-398 (2002). (Pubitemid 35001683)
50. Thalappilly, S., Soubeyran, P., Iovanna, J. L. & Dusetti, N. J. VAV2 regulates epidermal growth factor receptor endocytosis and degradation. Oncogene 29, 2528-2539 (2010).
51. Barber, M. A. & Welch, H. C. PI3K and RAC signalling in leukocyte and cancer cell migration. Bull. Cancer 93, E44-E52 (2006).
52. Tsukazaki, T., Chiang, T. A., Davison, A. F., Attisano, L. & Wrana, J. L. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 95, 779-791 (1998). (Pubitemid 29014458)
53. Hayes, S., Chawla, A. & Corvera, S. TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2. J. Cell Biol. 158, 1239-1249 (2002).
54. Kholodenko, B. N., Hancock, J. F. & Kolch, W. Signalling ballet in space and time. Nat. Rev. Mol. Cell Biol. 11, 414-426 (2010).
55. Sacks, D. B. The role of scaffold proteins in MEK/ERK signalling. Biochem. Soc. Trans. 34, 833-836 (2006). (Pubitemid 44796432)
56. Schuebel, K. E., Movilla, N., Rosa, J. L. & Bustelo, X. R. Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. EMBO J. 17, 6608-6621 (1998). (Pubitemid 28521795)
57. Liu, B. P. & Burridge, K. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins. Mol. Cell Biol. 20, 7160-7169 (2000).
58. Jones, M. C., Machida, K., Mayer, B. J. & Turner, C. E. Paxillin kinase linker (PKL) regulates Vav2 signaling during cell spreading and migration. Mol. Biol. Cell 24, 1882-1894 (2013).
59. Tamas, P. et al. Mechanism of epidermal growth factor regulation of Vav2, a guanine nucleotide exchange factor for Rac. J. Biol. Chem. 278, 5163-5171 (2003). (Pubitemid 36801028)
60. Aoki, K., Nakamura, T., Fujikawa, K. & Matsuda, M. Local phosphatidylinositol 3, 4, 5-trisphosphate accumulation recruits Vav2 and Vav3 to activate Rac1/Cdc42 and initiate neurite outgrowth in nerve growth factor-stimulated PC12 cells. Mol. Biol. Cell 16, 2207-2217 (2005). (Pubitemid 40632206)
61. Sturge, J., Wienke, D. & Isacke, C. M. Endosomes generate localized Rho-ROCK-MLC2-based contractile signals via Endo180 to promote adhesion disassembly. J. Cell Biol. 175, 337-347 (2006). (Pubitemid 44631427)
62. Caswell, P. T. et al. Rab-coupling protein coordinates recycling of alpha5beta1 integrin and EGFR1 to promote cell migration in 3D microenvironments. J. Cell Biol. 183, 143-155 (2008).
63. Schmidt, L. et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet. 16, 68-73 (1997). (Pubitemid 27198158)
64. Jeffers, M. et al. Activating mutations for the met tyrosine kinase receptor in human cancer. Proc. Natl Acad. Sci. USA 94, 11445-11450 (1997). (Pubitemid 27451018)
65. Bardelli, A. et al. Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth. Proc. Natl Acad. Sci. USA 95, 14379-14383 (1998). (Pubitemid 28549375)
66. Graveel, C. R., London, C. A. & Vande Woude, G. F. A mouse model of activating Met mutations. Cell Cycle 4, 518-520 (2005). (Pubitemid 41359769)
67. Muller, P. A. et al. Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion. Oncogene 32, 1252-1265 (2013).
68. Barrio-Real, L. & Kazanietz, M. G. Rho GEFs and cancer: linking gene expression and metastatic dissemination. Sci. Signal. 5, pe43 (2012).
69. Citterio, C. et al. The Rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells. Sci. Signal. 5, ra71 (2012).
70. Jeffries, T. R., Dove, S. K., Michell, R. H. & Parker, P. J. PtdIns-specific MPR pathway association of a novel WD40 repeat protein, WIPI49. Mol. Biol. Cell 15, 2652-2663 (2004). (Pubitemid 38691855)